Bausch + Lomb Corporation

Last updated September 27, 2026

Organization details

Legal name
Bausch + Lomb Corporation
Ownership
Public
Status
Active
Ticker symbol
BLCO
Primary stock exchange
NYSE

Identifiers

SEC CIK
0001860742

Board of directors

Chief executives

Brent L. Saunders · CEO and Chairman of the Board
Dates unknown

Board connections

15 of this board's directors also sit on 16 other boards.

Network of Bausch + Lomb Corporation's board connections Bausch Health Companies Inc. Bausch Health Companie... Acadian Asset Management Inc. Acadian Asset Manageme... Dana Incorporated Dana Incorporated International Flavors & Fragrances Inc. International Flavors... Newell Brands Inc. Newell Brands Inc. ARS Pharmaceuticals Inc. ARS Pharmaceuticals In... Ampco-Pittsburgh Corporation Ampco-Pittsburgh Corpo... CVR Energy Inc. CVR Energy Inc. Celularity Inc. Celularity Inc. Cencora Inc. Cencora Inc. Elevance Health Inc. Elevance Health Inc. Icahn Enterprises L.P. Icahn Enterprises L.P. SandRidge Energy Inc. SandRidge Energy Inc. SkinHealth Systems Inc. SkinHealth Systems Inc... TriSalus Life Sciences Inc. TriSalus Life Sciences... iRhythm Holdings Inc. iRhythm Holdings Inc. Barbara Trebbi Barbara Trebbi Brent L. Saunders Brent L. Saunders Brett Icahn Brett Icahn Eschenbach Andrew C. Von Eschenbach Andrew C.... Gaoxiang Hu Gaoxiang Hu John Paulson John Paulson Karen Ling Karen Ling Laurence E. Paul Laurence E. Paul Robert J. Chersi Robert J. Chersi Russel C. Robertson Russel C. Robertson Bausch + Lomb Corporation
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$1,224,173
9 purchases by 9 insiders
Sold, last 12 months
$1,194,370
3 sales by 2 insiders
Date Insider Transaction Shares Price Value
Aug 12, 2026 Robert J. Chersi Director Grant or award +11,776 — —
Aug 12, 2026 Laurence E. Paul Director Grant or award +11,776 — —
Aug 12, 2026 Barbara Trebbi Director Grant or award +11,776 — —
Aug 10, 2026 Munsch Frederick Officer (SVP, Controller and CAO) Open-market sale −52,900 $16.78 $887,662
Aug 7, 2026 Eschenbach Andrew C. Von Director Open-market sale −6,059 $16.58 $100,458
Aug 6, 2026 Eschenbach Andrew C. Von Director Open-market sale −12,500 $16.50 $206,250
Aug 5, 2026 Bailey A Robert D Officer (EVP & Chief Legal Officer) Grant or award +33,557 — —
Aug 5, 2026 Brent L. Saunders Director, Officer (Chairman of the Board and CEO) Shares withheld for tax −4,231 $16.76 $70,912
Aug 5, 2026 Bonnefoy Luc Officer (President, Surgical) Grant or award +16,778 — —
Aug 5, 2026 Sam Eldessouky Officer (EVP and CFO) Grant or award +50,335 — —
Aug 5, 2026 Hashad Yehia Officer (EVP of R&D and CMO) Grant or award +20,973 — —
Aug 5, 2026 Munsch Frederick Officer (SVP, Controller and CAO) Grant or award +9,091 — —
Aug 5, 2026 Stewart Andrew J. Officer (President, GPIC) Grant or award +16,778 — —
Aug 5, 2026 Brent L. Saunders Director, Officer (Chairman of the Board and CEO) Grant or award +281,879 — —
Jun 12, 2026 Bonnefoy Luc Officer (President, Surgical) Shares withheld for tax −1,008 $15.08 $15,201

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.